# MAZE (Maze Therapeutics, Inc.) - SEC EDGAR Financial Statements

> Maze Therapeutics, Inc. reported $511.6M in total assets and a net loss of $151.5M through December 31, 2025 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/MAZE
- Markdown: https://convexityos.com/fundamentals/MAZE.md
- SEC CIK: 0001842295
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:23 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001842295&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | -- | Dec 31, 2025 |
| Operating Income | FY 2025 | -$164.2M | Operating profit |
| Net Income | FY 2025 | -$151.5M | GAAP bottom line |
| Diluted EPS | FY 2025 | -$2.49 | Split-adjusted |
| Free Cash Flow | FY 2025 | -$115.3M | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $389.7M | Total debt: $59.64M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 |
| --- | --- | --- |
| **Revenue** | -- | $167.5M |
| Research & Development | $108.4M | $83.50M |
| Total Operating Expenses | $142.9M | $109.9M |
| **Operating Income** | -$142.9M | $57.59M |
| **EBITDA** | -$140.5M | $60.88M |
| Income Before Tax | -$131.1M | $53.40M |
| Income Tax Expense | $0 | $1.17M |
| **Net Income** | -$131.1M | $52.23M |
| Basic EPS | -$3.05 | $1.42 |
| **Diluted EPS** | -$3.05 | $1.25 |
| Basic Shares Outstanding | 43.0M | 2.4M |
| Diluted Shares Outstanding | 43.0M | 2.7M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $0 | $0 | $20.00M | -- | -- | $0 | -- | -- |
| Research & Development | $40.22M | $34.94M | $34.15M | $27.57M | $25.19M | $28.11M | $27.58M | $22.22M |
| Total Operating Expenses | $51.52M | $48.03M | $46.55M | $38.06M | $32.97M | $36.47M | $35.40M | $29.73M |
| **Operating Income** | -$51.52M | -$48.03M | -$26.55M | -$38.06M | -$32.97M | -$36.47M | -$35.40M | -$29.73M |
| **EBITDA** | -$51.13M | -$47.64M | -$26.11M | -$37.56M | -$32.39M | -$35.83M | -$34.72M | -$29.02M |
| Interest Expense | $975K | $931K | $866K | -- | -- | -- | -- | -- |
| Income Before Tax | -- | -- | -- | -$34.57M | -$30.09M | -$33.68M | -$32.79M | -$29.85M |
| Income Tax Expense | -- | -- | -- | -- | $0 | $0 | -- | -- |
| **Net Income** | -$47.97M | -$44.73M | -$24.21M | -$34.57M | -$30.09M | -$33.68M | -$32.79M | -$29.58M |
| Basic EPS | -$0.79 | -$0.76 | -$0.45 | -- | -$0.66 | -$0.77 | -$1.15 | -- |
| **Diluted EPS** | -$0.79 | -$0.76 | -$0.45 | -- | -$0.66 | -$0.77 | -$1.15 | -- |
| Basic Shares Outstanding | 60.9M | 59.0M | 53.9M | -- | 45.8M | 43.8M | 28.6M | -- |
| Diluted Shares Outstanding | 60.9M | 59.0M | 53.9M | -- | 45.8M | 43.8M | 28.6M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 |
| --- | --- | --- |
| Cash & Cash Equivalents | $189.2M | $196.8M |
| Short-Term Investments | $152.7M | -- |
| **Cash & Short-Term Investments** | $341.9M | $196.8M |
| **Total Current Assets** | $349.7M | $201.7M |
| Property, Plant & Equipment, Net | $5.04M | $6.67M |
| Long-Term Investments | $18.11M | -- |
| Other Non-Current Assets | $3.05M | $7.87M |
| **Total Non-Current Assets** | $47.41M | $38.87M |
| **Total Assets** | $397.1M | $240.5M |
| Accounts Payable | $1.79M | $1.94M |
| **Total Current Liabilities** | $22.56M | $20.67M |
| Other Non-Current Liabilities | $1.09M | $969K |
| **Total Non-Current Liabilities** | $19.61M | $22.96M |
| **Total Liabilities** | $42.16M | $43.64M |
| **Total Debt (incl. Leases)** | $23.31M | $26.63M |
| Common Stock | $49K | $2.0K |
| Retained Earnings | -$489.5M | -$358.4M |
| **Total Stockholders' Equity** | $355.0M | -$311.2M |
| Total Equity | $355.0M | -$311.2M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $154.2M | $202.6M | $198.8M | $189.2M | $316.8M | $264.5M | $294.4M | $196.8M |
| Short-Term Investments | $235.5M | $208.4M | $153.6M | $152.7M | $67.16M | -- | -- | -- |
| **Cash & Short-Term Investments** | $389.7M | $411.1M | $362.9M | $341.9M | $383.9M | $264.5M | $294.4M | $196.8M |
| Accounts Receivable, Net | -- | -- | $20.00M | -- | -- | -- | -- | -- |
| **Total Current Assets** | $400.1M | $420.4M | $379.8M | $349.7M | $391.3M | $271.1M | $299.7M | $201.7M |
| Property, Plant & Equipment, Net | $4.35M | $4.39M | $4.68M | $5.04M | $5.54M | $6.01M | $6.31M | $6.67M |
| Long-Term Investments | $87.32M | $83.82M | $10.56M | $18.11M | -- | -- | -- | -- |
| Other Non-Current Assets | $1.10M | $3.46M | $4.32M | $3.05M | $3.21M | $3.57M | $3.25M | $7.87M |
| **Total Non-Current Assets** | $111.5M | $111.2M | $39.93M | $47.41M | $30.76M | $32.37M | $33.13M | $38.87M |
| **Total Assets** | $511.6M | $531.6M | $419.7M | $397.1M | $422.1M | $303.5M | $332.8M | $240.5M |
| Accounts Payable | $4.57M | $2.21M | $4.01M | $1.79M | $2.92M | $3.67M | $2.40M | $1.94M |
| Short-Term Debt | $0 | $0 | $0 | -- | -- | -- | -- | -- |
| **Total Current Liabilities** | $28.30M | $22.96M | $21.24M | $22.56M | $22.11M | $19.90M | $18.62M | $20.67M |
| Long-Term Debt | $39.12M | $38.96M | $38.83M | -- | -- | -- | -- | -- |
| Other Non-Current Liabilities | -- | -- | $388K | $1.09M | $1.09M | $1.09M | $1.01M | $969K |
| **Total Non-Current Liabilities** | $54.71M | $55.54M | $56.77M | $19.61M | $20.51M | $21.38M | $22.16M | $22.96M |
| **Total Liabilities** | $83.01M | $78.50M | $78.01M | $42.16M | $42.62M | $41.28M | $40.77M | $43.64M |
| **Total Debt (incl. Leases)** | $59.64M | $60.42M | $61.22M | $23.31M | $24.18M | $25.01M | $25.82M | $26.63M |
| Common Stock | $56K | $56K | $50K | $49K | $48K | $44K | $44K | $2.0K |
| Retained Earnings | -$606.5M | -$558.5M | -$513.8M | -$489.5M | -$455.0M | -$424.9M | -$391.2M | -$358.4M |
| **Total Stockholders' Equity** | $428.5M | $453.1M | $341.7M | $355.0M | $379.4M | $262.2M | $292.1M | -$311.2M |
| Total Equity | $428.5M | $453.1M | $341.7M | $355.0M | $379.4M | $262.2M | $292.1M | -$311.2M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 |
| --- | --- | --- |
| Net Income | -$131.1M | $52.23M |
| Depreciation & Amortization | $2.40M | $3.30M |
| Stock-Based Compensation | $16.40M | $9.65M |
| Change in Payables | -$27K | -$204K |
| **Operating Cash Flow** | -$111.9M | $75.95M |
| Capital Expenditure | -$794K | -$1.15M |
| **Free Cash Flow** | -$112.7M | $74.81M |
| Purchases of Investments | -$187.7M | -- |
| **Investing Cash Flow** | -$171.0M | -$1.15M |
| **Financing Cash Flow** | $275.3M | $92.85M |
| **Net Change in Cash** | -$7.57M | $167.7M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$47.97M | -$44.73M | -$24.21M | -$34.57M | -$30.09M | -$33.68M | -$32.79M | -$29.58M |
| Depreciation & Amortization | $385K | $391K | $444K | $499K | $571K | $649K | $684K | $705K |
| Stock-Based Compensation | $8.54M | $9.19M | $7.11M | $6.07M | $3.86M | $3.24M | $3.23M | $2.85M |
| Change in Receivables | -- | -- | -$20.00M | -- | -- | -- | -- | -- |
| Change in Payables | $2.35M | -$1.79M | $2.21M | -$1.12M | -$748K | $1.27M | $579K | $821K |
| **Operating Cash Flow** | -$32.84M | -$15.05M | -$39.11M | -$27.73M | -$24.64M | -$30.05M | -$29.52M | -$22.45M |
| Capital Expenditure | -$288K | -$107K | -$93K | -$34K | -$68K | -$393K | -$299K | -$605K |
| **Free Cash Flow** | -$33.13M | -$15.16M | -$39.21M | -$27.76M | -$24.71M | -$30.45M | -$29.82M | -$23.06M |
| Purchases of Investments | -$68.12M | -$162.4M | -$23.63M | -- | -- | -- | -- | -- |
| **Investing Cash Flow** | -$31.41M | -$128.5M | $6.28M | -$103.4M | -$66.88M | -$393K | -$299K | -$605K |
| **Financing Cash Flow** | $15.77M | $147.4M | $42.36M | $3.59M | $143.8M | $612K | $127.4M | $70.26M |
| **Net Change in Cash** | -$48.49M | $3.88M | $9.52M | -$127.5M | $52.23M | -$29.83M | $97.56M | $47.20M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 |
| --- | --- | --- |
| **Operating Margin** | -- | 34.4% |
| **Net Profit Margin** | -- | 31.2% |
| Return on Equity (ROE) | -36.9% | -- |
| Return on Assets (ROA) | -33.0% | 21.7% |
| Current Ratio | 15.50x | 9.76x |
| Quick Ratio | 15.16x | 9.52x |
| Debt to Equity | 0.07x | -- |
| Operating Income Growth (YoY) | -348.1% | -- |
| **Net Income Growth (YoY)** | -351.0% | -- |
| EPS Growth (YoY) | -314.8% | -- |
| Operating Cash Flow Growth (YoY) | -247.4% | -- |
| Free Cash Flow Growth (YoY) | -250.7% | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -35.3% | -29.5% | -35.9% | -36.9% | -33.2% | -46.1% | 17.8% | -- |
| Return on Assets (ROA) | -29.6% | -25.1% | -29.2% | -33.0% | -29.9% | -39.8% | 15.6% | 21.7% |
| Current Ratio | 14.14x | 18.31x | 17.88x | 15.50x | 17.70x | 13.63x | 16.10x | 9.76x |
| Quick Ratio | 13.77x | 17.90x | 18.03x | 15.16x | 17.36x | 13.29x | 15.81x | 9.52x |
| Debt to Equity | 0.14x | 0.13x | 0.18x | 0.07x | 0.06x | 0.10x | 0.09x | -- |
| **Revenue Growth (YoY)** | -- | -- | -- | -- | -- | -100.0% | -- | -- |
| Operating Income Growth (YoY) | -- | -- | -- | -- | -- | -126.1% | -- | -- |
| **Net Income Growth (YoY)** | -- | -- | -- | -- | -- | -124.2% | -- | -- |
| EPS Growth (YoY) | -- | -- | -- | -- | -- | -113.0% | -- | -- |
| Operating Cash Flow Growth (YoY) | -- | -- | -- | -- | -- | -120.7% | -- | -- |
| Free Cash Flow Growth (YoY) | -- | -- | -- | -- | -- | -121.0% | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
